{"schema_version":"secwatch.filing_event.v1","accession":"0001185185-21-001432","form_type":"8-K/A","ticker":"FUST","cik":"0001636051","company_name":"FUSE GROUP HOLDING INC.","filed_at":"2021-10-01T23:59:59+00:00","discovered_at":"2026-05-14T18:04:13.420896+00:00","generated_at":"2026-06-28T23:58:43.165279+00:00","sec_items":["1.01","3.02","5.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Fuse Group issues 100M shares for E-Mo Biotech; Xie becomes 31.97% owner","bullets":["Fuse Group acquired all of E-Mo Biotech in exchange for 100 million common shares.","E-Mo Biotech is a development-stage vaccine/immunology/diagnostics firm with no commercial sales.","Qiyi Xie receives 57.25M shares (31.97% of Fuse Group) and becomes largest shareholder, replacing Landbond Home.","Shares issued to Xie under Reg D; to other sellers under Reg S; no underwriter used."],"urls":{"canonical":"https://secwatch.observer/filing/0001185185-21-001432","json":"https://secwatch.observer/filing/0001185185-21-001432.json","markdown":"https://secwatch.observer/filing/0001185185-21-001432.md","text":"https://secwatch.observer/filing/0001185185-21-001432.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1636051/000118518521001432/0001185185-21-001432-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1636051/000118518521001432/fuseent20210929_8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T23:58:43.165279+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}